Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592314 | SCV000701524 | uncertain significance | not provided | 2018-08-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001867916 | SCV002253072 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2P; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 | 2022-06-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with DAG1-related conditions. This variant is present in population databases (rs745350022, gnomAD 0.01%). This variant, c.1877_1879del, results in the deletion of 1 amino acid(s) of the DAG1 protein (p.Lys626del), but otherwise preserves the integrity of the reading frame. |